Related Experiment Videos
Fibrinogen as a factor of thrombosis: experimental study
F Doutremepuich1, O Aguejouf, E Belougne-Malfatti
1Laboratoire d'Hématologie, Faculté de Pharmacie, Bordeaux, France. secrheph@hippocrate.u-Bordeaux2.FR
Thrombosis Research
|July 31, 1998
Summary
Elevated fibrinogen levels increase the risk of blood clots (thromboembolism). This study shows that administering fibrinogen in rats enhances thrombus formation and platelet aggregation, confirming its role in thrombotic events.
Area of Science:
- Hematology
- Cardiovascular Research
- Thrombosis Research
Background:
- Baseline fibrinogen levels are strongly associated with thromboembolic complications.
- Plasma fibrinogen levels play a role in the pathogenesis of postoperative and post-traumatic thrombosis.
Purpose of the Study:
- To evaluate the dose-dependent effects of fibrinogen administration on thrombus formation.
- To investigate the impact of fibrinogen on thrombosis in a rat microcirculation model.
Main Methods:
- An experimental model using laser-induced endothelial cell destruction in rat microcirculation was employed.
- Fibrinogen was administered intravenously at dosages of 50, 100, and 200 mg/kg.
- Arterial and venous thrombosis induction occurred at 60 and 120 minutes post-injection, respectively.
Main Results:
- Fibrinogen administration significantly increased the number and duration of emboli.
- Ex-vivo platelet aggregation induced by ADP was enhanced in amplitude and velocity.
- A positive correlation was observed between increased plasma fibrinogen and enhanced thromboembolic risk.
Conclusions:
- Fibrinogen administration potentiates thrombus formation and thromboembolic risk.
- These findings support the role of fibrinogen as a key factor in thrombotic processes.
- The study highlights fibrinogen's impact on platelet aggregation and embolization dynamics.